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Summary
Constitutive production of cytokines was observed in 3 o£ 12 ylb T cell linesderived from murine
epidermis and correlated with the expression of the Cy4, V66 T cell receptor (TCR). After
adaptation of one of the lines (T195/BW) to serum-free culture conditions, cessation of the
"spontaneous" production of interleukin 4 (IJ. 4) was observed and 11=4 production could then
be induced by the addition ofRGD-containing extracellular matrix (ECM) proteins to the culture.
The response to the ECM proteins could be completely inhibited by a mAb to the murine vitronectin
receptor (VNR). However, the induction of IL -4 production couldalso be inhibited by anti-CD3
and by an anti-clonotypic mAb to the TCR-y/b of T195/BW As TCR-ylb loss mutants of
T195/BW also failed to respond to ECM proteins, these data demonstrate that engagement of
the VNR by its ligand is necessary, but not sufficient, for the induction of IL4 production.
Furthermore, the VNR is expressed by many other T cell clones (both y/b and x//3), none
of which produce lymphokines constitutively. Taken together, these observations strongly favor
the view that not only is coexpression of the VNR and TCR required for the induction of IL4
production, but that the TCR must also be engaged by its ligand, most likely a cell surface
antigen expressed by the hybridoma itself.
T lymphocytes can be divided into two major lineages
based on the molecular characteristics of their receptors.
The major subpopulation of peripheral T lymphocytes ex-
press ct/a chains and recognize peptide antigens in associa-
tion with either MHC class I or class 11 molecules. Although
numerous recent studies have documented the existence of
a second subpopulation of lymphocytes that express TCR
y1b chains, a consensus view does not exist either concerning
the nature ofthe antigen recognized by the TCR-y/b or the
nature of the restriction element, if any, utilized by this popu-
lation of cells (1). A number of laboratories have reported
the characteristicsofy/b clones/lines that recognize allo- and
self-MHC including both class 1(2, 3), class 11(4), and non-
classical MHC antigens (5-7). Certain y/b T cell clones have
been generated that recognize conventional protein antigens
(8, 9) and studies from several laboratories have suggested
that y/b T cells may play a unique role in host defense against
certain bacterial infections because their receptors are skewed
to recognize a set of bacterial antigens (10-14), particularly
mycobacterial heat shock proteins (15-17). Although it has
been reported that protein antigen specific y1b T cell clones
may use conventional MHC class 11 antigens (8) or nonclas-
sical MHC antigens (9) as restriction elements, many antigen-
specific -y1b T cells demonstrate no specific MHC restriction
(14) or no requirement for the addition ofnon-T APCs (15).
These latter results do not rule out the possibility that the
clones present antigen to themselvesand use an uncharacter-
ized cell surface antigen as a restriction element that may ex-
hibit limited polymorphism.
Because y/b T cells are predominantly CD4 - , CD8 - , an
alternative approach to the analysis of y/b T cell function
has been to define unique cell surface antigens, in addition
to the TCR, which are expressed on this population of cells
and might play a role in their function, possibly as accessory
molecules for the recognition of antigen (18, 19). During
the course of such studies, we identified (20) two mAbs to
a novel integrin on murine lymphoid cells that was expressed
on many y/b T cell lines and hybridomas as well as on cilO
T cell lines and chronically activated ulo T cells in vitro.
The antigen family of cell surface heterodimers consists of
at least three groups ofcell surface antigens which are identified
by their usage of a commona which is associated with one
ofseveral ct chains (21). The VLA antigens use the #1 chain,
the leukocyte adhesion proteins the 02 chain, and the cyto-
adhesins the (33 chain. Recent studies have documented the
existence of other (3 chains (22-24). The integrin identified
on murine cells by our mAbs mediated cell binding to the
extracellular matrix (ECM)' proteins, fibronectin, fibrinogen,
'Abbreviations used in this paper . DETC, dendritic epidermal T cells; ECM,
extracellular matrix; VNR, vitronectin receptor.
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231-240and vitronectin and adhesion could be completely inhibited
by the tetrapeptide RGDS. Although the precise molecular
relationship of this integrin to the proposed classification
system of human integrins has not been determined, we have
recently shown (24a) that this murine integrin is likely to
be a member of the 03 family, most likely the vitronectin
receptor (VNR).
In this report, we characterize several .y/6 cell lines de-
rived from murine dendritic epidermal T cells (DETC) that
produce substantial amounts of cytokines in culture in the
apparent absenceofstimulation by exogenous agents. We dem-
onstrate that this "spontaneous" production of cytokines re-
quires the expression of the VNR and the interaction of the
VNR with RGD-containing ECM proteins. Furthermore,
this phenomenon is associated with the usage of the Cy4,
V66 TCR and is absolutely dependent on expression of this
TCR. Collectively, these data strongly suggest that the VNR
plays a critical role as an accessary molecule in the stimula-
tion of the C-y4, VS6 subset of cells.
Materials and Methods
CeII Lines.
￿
The DETC lines Y93A, Y245, and the T195/BW
hybridoma have been previously described (25-28) and are grown
in RPMI 1640 supplemented with 10% FCS, 5 mM Hepes, 1 mM
sodium pyruvate, nonessential amino acids, 2 mM glutamine, pen-
icillin/streptomycin, and 5 p.M 2-ME (CM-RPMI). The T195 cell
line was grown in CM-RPMI supplemented with 20% rat Con
A supernatant. Each adherant line was removed from plastic by
treatment with PBS and 0.02% EDTA before resuspension in
CM-RPMI. DETC were also grown in AIM V media (Gibco
Laboratories, Grand Island, NY) without serum, but otherwise
supplemented as described for RPMI-CM. CTLL cells were main-
tained as previously described (29). CT4S was grown in CM sup-
plemented with 500 U/ml rI1,4 and the DA-1 line was grown in
5% WEHI-3 supernatant .
Reagents.
￿
Vitronectin, fibronectin, and PepTite 2000 were ob-
tained from Telios Pharmaceuticals, Inc. (San Diego, CA). Rat col-
lagen IV, BSA, PMA, and ionomycin were purchased from Sigma
Chemical Co., St. Louis, MO. Peptides (RGDS, GRGDS, RGES)
used in inhibition experiments were purchased from Peninsula
Laboratories, Inc. (Belmont, CA). Proteolytic fragments ofhuman
fibronectin were kindly provided by Joyce Czop (Harvard Medical
School, Boston, MA) and have previously been described (30).
Production of Lymphokine-containing Supernatants.
￿
DETC were
incubated at a concentration of 2.5 x 105 in 1.0 ml of CM-RPMI
or AIM V mediain 24-well cluster plates overnight. Supernatants
were harvested and frozen at -20°C before assayfor lymphokines.
Wells of 24-well cluster plates were incubated overnight at 37°C
with 1.0 ml of ECM protein or mAb in PBS. Wells were subse-
quently washed three times with PBS before use.
Lymphokine Assays.
￿
11,2 was assayed on CTLL cells responsive
toboth IL,2 and IIr4 as previouslydescribed (29). IL-4 was specifically
assayed using the CTAS cell that is responsiveto 11,4, but not IT,2
(29). Granulocyte/macrophage CSF (GM-CSF) was assayed using
DA-1 cells. Supernatants were titratedby doubling dilutions in 96-
well microtiter plates before adding the indicator cells (5,000
cells/well, total volume of 200 pl). After 48 h, 1.0 pCi of
['H]TdR was added and plates were harvested 5 h later. Units
were defined as the reciprocalof the dilution ofsupernatant (x 100)
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required to induce a half-maximal proliferative response of the in-
dicator cell line.
Production of TCR Loss Mutants of T1951BW.
￿
TCR loss mu-
tants of T195/BW were prepared by exposing cells to ethylmethane
sulphonate (Sigma Chemical Co.), 200 pg/ml for 24 h at a cell
concentration of 2.5 x 105/ml. Mutagenized cells were grown in
CM-RPMI for 7dbefore selection using the F10/56 antibody (1/100
diluted ascites) in the presence of rabbit complement (1/10 dilu-
tion; Cedarlane Laboratories, Hornby, Ontario). Negative selec-
tion with F10/56 and complement was repeated on three succes-
sive days to yielda preparation that was 20-30% positive by staining
with F10/56. These cells were then cloned by limiting dilution
and the clones were subsequently screened by staining with F10/56-
FITC and analysis using a FACSCAN (Becton Dickinson & Co.,
Mountain View, CA) .
Purification of mAbs.
￿
The anti-clonotypic mAb F10/56 was
generatedby immunization of a hamsterwith T195/BW cells. Fur-
ther characterization of this mAb will be presented elsewhere
(Roberts, K., and E. M. Shevach, manuscript in preparation). The
mAbs H1.2F3 (18), 2C11 (31) and H9 .2 (20) were purified from
hybridoma supernatants on protein A-Sepharose amity columns
(Pharmacia Fine Chemicals, Piscataway, NJ). Ml/9.3.4.HL.2 (Ml/9;
32) and 8.18 (20) were purified on a mouse anti-rat « (MAR 18.5)
affinity column. The hamster mAb F10/56 was purified on a mouse
anti-rat rc (RG7/7, cross-reactive with hamster; 33) affinity column.
Antibody was subsequently eluted from the columns at pH 4.3
and dialyzed against PBS. Contaminant fibronectin was removed
by passage ofaffinity pure antibody preparations over heparin agarose
columns (Sigma Chemical Co.) before use in functionalexperiments.
Results
Inhibition ofthe Constitutive Production ofLymphokines by mAbs
Against the TCR. In an attempt to evaluate the activation
requirements and growth properties of 7/6 T cells, a panel
of murine DETC lines as well as T cell hybridomas derived
from those lines were tested for their ability to produce a
varietyoflymphokines. Surprisingly, 3of 12 lines/hybridomas
tested produced lymphokines when the cells were incubated
in the absence of exogenous growth factors or stimulatory
ligands. When tested on factor-dependent cell lines in the
presence of specific antilymphokine mAbs, two of the cell
lines (Y93A and Y245) produced GM-CSF, but not IIr2 or
11,4, while one of the cell lines (T195) produced only 1174
(data not shown). Interestingly, all three of the T cell lines/hy-
bridomas that were capable of spontaneous cytokine produc-
tion have closely related TCRs insofar as they are known to
express both Vy1.1 C-y4 and VS6 chains (25, 27, 28). T195
and T195/BW (a hybridoma made by fusion of this line to
BW5147) only express the C-y4, VS6 receptor, while Y93A
and Y245 also have functional mRNA for Cy1 and a second
TCR composed of Cy1, VS6 chains can be immunoprecipi-
tated from surface-labeled cells (28) . The nine other DETC
lines and hybridomas that did not produce lymphokines in
the absence of stimulation all express the V-y3Cy1 and V61
chains (27).
Since these data suggested a correlation between the ex-
pression ofthe Cy4, V66 TCR and the phenotypeofconsti-
tutive lymphokine production, we sought further evidenceSupernatants from DETC cultures were assayed for lymphokine. Results are expressed as cpm and represent [3H]TdR incorporation of indicator
cells using 6.25% DETC supernatant . DA-1 cells were used in Exp. 1 and CTLL used in Exps. 2 and 3. In Exps. 1 and 2, purified mAbs were
either added to the culture medium or immobilized on plates (used at 20 wg/ml in both cases). In Exp. 3, antibodies were added to the culture
media (5.0 pg/ml).
that the TCR was involved. Inhibition of GM-CSF produc-
tion by both Y93A and Y245 cell lines was observed when
these lines were cultured in the presence of soluble, but not
immobilized, anti-CD3 (Table 1, Exp. 1). Similarly, IL4
productionby the T195 cell line as well as by the T195/BW
hybridoma was markedly inhibited when the cells were cul-
tured in the presence of soluble anti-CD3 mAb, but not when
the cells were exposed to the same mAb immobilized on plastic
(Table 1, Exp. 2). It would therefore seem unlikely that en-
gagement of the TCR per se inhibits the productionoflym-
phokine by these cells. Moreover, a mAb (F10/56) reactive
with clonotypic determinants ofthe T195 TCR-y/6 also in-
hibited IL4 production when added in soluble form (Table
1, Exp. 3) . These results confirm and extend to nontrans-
formed cell lines the observations of O'Brien et al. (15) who
demonstrated an association between the expression of Cy4
and V66 in a large panel of T cell hybridomas derived from
newborn thymus and spontaneous IL2 production and a
similar inhibition by soluble anti-CD3. Although stimula-
tion via the TCR may lead to growth arrest of T cell hybrid-
omas (34), the proliferation of T195/BW was identical in
the presence or absence of anti-CD3. In subsequent experi-
ments, T195/13W was used exclusively because of its ease of
growth, its susceptibility to inhibition by anti-CD3, and the
availability of the anti-clonotypic mAb F10/56.
Activation Properties of T1951BW Cultured in Serum Free
Medium. The ability of anti-CD3 and the anti-clonotypic
mAb to inhibit IL4 production by T195/BW when used
in soluble, but not plate-bound, form raised the possibility
that the anti-CD3/TCR mAbs inhibited T cell activation
by blocking the recognition of antigen present in the culture
medium or present on the T cell hybridoma itself. T195/BW
was therefore adapted to "serum-free" culture conditions (AIM
V medium) to assess the possible involvement of an antigen
present in FCS. Cells grown in AIM V proliferated as well
as those grown in RPMI containing 10% FCS or AIM V
supplemented with FCS (data not shown). However, no IL4
was detected in the supernatants of T195/BW grown in AIM
V, while supplementation of the AIM V with FCS resulted
233
￿
Roberts et al.
in ILA production (Table 2). In contrast to the lack of effect
of immobilized anti-CD3 on T195/13W cells grown in serum,
the hybridoma cells grown in AIM V without FCS could
be induced to produce levels of 114 with either immobilized
anti-CD3 or the clonotypic mAb, F10/56, comparable to those
observed by serum stimulation (Table 2). Immobilized mAbs
specific for the VNR (H9.2) and the murine CD45 homo-
logue (M1.9), antigens expressed by the hybridoma, failed
to induce lymphokine production.
The Serum Components Responsible for 11,4 Production are
ECMProteins. One of the most striking differences between
T195/BW cells grown in serum and T195/BW grown in
AIM V was that the former grew in a strongly adherent
monolayer, while the latter grew in suspension culture. Fur-
thermore, addition of serum to the AIM V media induced
rapid adhesion of the T195/BW cells to plastic and subse-
Table 2 .
￿
IL-4 Production by T195/BW After Stimulation by
Immobilized Antibodies
Culture conditions IL-4 production
U/ml
AIM V
￿
0
Anti-CLA (M1 .9)
￿
0
Anti-VNR (H9.2)
￿
0
Anti-VNR (8.18)
￿
0
Anti-CD3
￿
425
Anti-clonotype(F10/56)
￿
222
FCS
￿
250
PMA + lonomycin
￿
1,597
T195/13W cells were cultured in AIM V on plates coated with antibodies
(20 ttg/ml) or in the presence of FCS (10%) or PMA (10 ng/ml.) and
ionomycin (400 ng/ml.). Supernatants were harvested after 18 h and as-
sayed on CTAS for IL-4 content.
Table 1 . Inhibition of Constitutive Lymphokine Production by Soluble Antibodies to the TCR
Anti-CD3 Anti-CD3 Anti-CD69 Anti-Clono (T195)
Exp. DETC line Medium (sol.) (imm.) (sol.) F10/56 (sol.)
1 Y93A 35,160 18,021 43,384 ND ND
Y245 71 .494 34,721 75,287 ND ND
2 T195/13W 22,751 1,798 25,559 ND ND
3 T195/BW 40,016 753 ND 51,090 13,149
T195 69,696 8,164 ND 77,287 9,915quent spreading. It has been previously demonstrated (20)
that this hybridoma adheres to fibronectin, fibrinogen, and
vitronectin, all of which are present in serum. Moreover,
precoating plates with serum wasjust as effectiveat inducing
ILA production as including it in the culture media (Table
3). Collectively, theseobservations raised the possibility that
cell adherancewas related to lymphokine production in FCS
containing media. To address this issue, T195/13W cells, which
had been grown in AIM V for 3 wk, were cultured in AIM
V on plates coated with variousECM proteins. ILAproduc-
tion was observed (Table 3) when the hybridomawas incubated
overnight on plates coated with human fibronectin, mouse
fibronectin, or human vitronectin (and fibrinogen, data not
shown), butnotwith ratcollagen or BSA. Thus, thespecificity
of the induction of IL4 production by the ECM proteins
is identical to thepreviously described (20) specificity of the
adhesion ofT195/BW to ECMproteins mediated by the inte-
grin identified by mAb H9.2.
It has previously been demonstrated that the amino acid
tripeptide, RGD, is one of the cell attachment sites on the
fibronectin, fibrinogen, and vitronectin molecules (35, 36).
To further evaluate whetherECMproteins containing RGD
were the only components in serum that mediated the acti-
vation of T195/BW, we examined the effect of addition of
the synthetic peptide RGDS on the constitutive production
of IL-4 by this cell when it is maintained in serumcontaining
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Table 3.
￿
Induction of IL-4 Secretion by T1951BW by Serum
and ECMProteins
FCS concentration
Soluble
Plate bound
ECM protein concentration
T195/BWcell in AIMVwere incubated (18h) on plates precoated with
different concentrations of ECMproteins. Supernatants were subsequently
assayed for IL-4 as in the legend to Table 2. T195/BW hybridoma cells
incubated in AIM V alone made 0 U/ml IL-4.
Results are expressed as units per milliliter of IL-4.
T195/BWcells grownin RPMI containing 10% FCSwere washed and then recultured in RPMI containing 10% FCS (Exp. 1). In Exp. 2, T195/BW
cells grown in AIM V were cultured in AIM V on fibronectin (1.0 14g/ml) coated plates, in AIM V supplemented with 5% FCS, or in AIM V
on plates coated with anti-CD3 (2C11, 20 Wg/ml). peptides were addedto theculture medium at theconcentrations indicated. After 18 h ofculture,
supernatants were assayed for IL-4 content as in the legend to Table 2.
" Results are expressed as units per milliliter of IL-4.
￿
-
Table 4. Peptide Inhibition of IL-4 Production by T1951BW
Peptide Concentration
Exp. Stimulus Peptide 0.625 2.5 10.0 40.0
hg/ml
1 FCS Medium 299
RGES 294 286 286
RGDS 250 310 <1
2 Fibronectin Medium 327
RGES 328 317 317 305
RGDS 161 <1 <1 0
FCS Medium 190
RGES 167 152 189 189
RGDS 122 43 0 0
Anti-CD3 Medium 304
RGES 345 323 323 294
RGDS 303 345 351 328
10.0 1.0 0.1
mg/ml
Fibronectin (mouse) 426 735 0
Fibronectin (human) 556 1,220 0
Vitronectin (human) 384 870 0
Collagen type IV (rat) <1 0 0
Albumin (bovine) 0 0 0
10.0 1.0 0.1
95"
250
1,515
1,250
1,887
1,316medium. The addition of RGDS, but not the control pep-
tide RGES, inhibited by >95% the production of IL4 by
T195/BW in serum containing medium (Table 4, Exp. 1).
Thus, RGDS-containing proteins are responsible for almost
all of the effects of serum on the activation of T195/BW
Very similar results were obtained when the T195/BW cells
that had been adapted to AIM V were stimulated with plate-
bound fibronectin, or serum, but not immobilized anti-CD3
(Table 4, Exp.-2). Since activation by immobilized anti-CD3
was not affected by the RGDS peptide, these results demon-
strate that the inhibition of the response to serum or ECM
proteins by RGDS is specific, and further demonstrate that
RGDS induced inhibition ofIL4 production is not secondary
to the delivery of a negative signal.
The RGDS Sequence Is Sufficientto Stimulate the T195/BW
Hybrid. The minimum portion of the fibronectin molecule
required to stimulate T195/13W was investigated usingpro-
teolytic fragments of human fibronectin (Table 5, Exp. 1).
Costar wells were coated with each of the fibronectin frag-
ments and then blocked with BSA. Any fragment containing
the cell attachment domain was sufficient to trigger IL A
production and these fragments were as efficient as the whole
fibronectin molecule. Fragments containing the gelatin binding
site or the heparin binding site failed to stimulate; a very low
level of stimulation was observed using the 29-kD NH2-
terminal fragment.
The stimulatory sequence in fibronectin was further defined
by using a commercial peptide of 2,000 daltons molecular
weight (Pep Tite 2000) that contains the RGDS cell attach-
ment sequence and a highly charged sequence of amino acids
that facilitate its binding to plastic. Plates coated with Pep-
Tite 2000 (1.0 l, tg/ml) were as effective as plates coated with
the intact fibronectin molecule (1.0 14g/ml) in the induction
of IL4 production by T195/BW (Table 5, Exp. 2). This re-
sult is most consistent with the view that sequences outside
the cell attachment site on ECM proteins are not required
to trigger T195/BW Furthermore, it is also very unlikely
that the TCR plays any direct role in the recognition of the
ECM proteins as both the integrin and the TCR would then
be required to simultaneously bind to the RGDS sequence.
The VNR Identified by mAb HQ.2 Mediates the Stimulation
of T1951BW by ECMProteins. One likely candidate for the
integrin responsible for the activation ofT195/BW cellswas
the heterodimer recognized by mAbs H9.2 and 8.18, which
we have previously shown to be expressed on many of the
y/S DETC cell lines as well as on T195/BW hybridoma cells
(20) . T195/BW cells maintainedin serum free medium were
stimulated with immobilized murine fibronectin or by sup-
plementing the medium with FCS (5% final). IL4 produc-
tion induced by either fibronectin or serum was completely
inhibited by mAb H9.2 (Table 6), while mAb 8.18 which
recognizes a distinct site on the 120-kD fragment o£ the a
chain of the integrin heterodimer produced much less inhi-
bition. This result differs from the effects of these mAbs on
cell adhesion where the simultaneous addition ofboth H9.2
and 8.18 was required to block adhesion (20) . The addition
of anti-CD3 also resulted in complete inhibition ofIL4 produc-
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Table 5 .
￿
Induction of IL-4 Production by T195/BW After
Stimulation with Proteolytic Fragments of Fibronectin Containing
the Cell Attachment Site or PepTite 2000
Exp. Culture conditions
In Exp. 1, T195/BW cells grown in AIM V media were cultured in
AIM V on plates precoated with 1.0 ug/ml of whole or proteolytic frag-
ments of human fibronectin. One aliquot of cells was stimulated with
PMA/Ionomycin and a second aliquot was cultured in 5% FCS. In Exp.
2, cells were stimulated with either murine fibronectin or PepTite 2000.
IL-4 production was assayed in both experiments as in Table 2.
tion, while mAbs H1.2F3 (anti-CD69) and M1.9 (anti-CD45,
data not shown), which are directed to othercell surface an-
tigens expressed on the hybridoma, failed to inhibit. IL4
production could also not be inhibited by anti-MHC class
I, anti-MHC classII, or anti-LFA1 mAbs (data not shown).
Table 6.
￿
The Fibronectin and Serum Induction of IL-4
Production by T195/BW is Inhibited by Antibodies to the VNR
IL-4 production
T195/13W cells adapted to grow in AIM V were stimulated in AIM V
on plates coated with murine fibronectin (1.0 NAg/ml) or in the presence
ofFCS (5.0%). Soluble mAbs (5 tag/ml) were added to the culture media
and culture supernatants harvested following an 18-h incubation. IL-4
content of the supernatants was assayed as in the legend to Table 2.
Units per milliliter of IL-4.
U/ml
1 Whole fibronectin 8,333
NH2 terminus fragment 67
Gelatin binding fragment 2
Heparin binding fragment 5
Cell attachment site fragment 26,315
PMA + Ionomycin 5,000
FCS 714
Media alone 4
2 Fibronectin (1 .0 Ag/ml) 1,818
Fibronectin (10.0 wg/ml) 1,099
PepTite 2000 (1.0 hg/ml) 1,380
PepTite 2000 (10.0 t~g/ml) 925
PMA + Ionomycin 2,439
FCS 513
Media alone 0
Culture Conditions Fibronectin FCS
Media alone 588' 800
Anti-CD69 (111-2F3) 800 1,600
Anti-CD3 (2C11) 0 0
Anti-VNR (119.2) 0 0
Anti-VNR (8 .18) 200 400Co-Expression ofthe TCR Is Requiredfor Integrin-mediated
T Cell Activation. Although these studies strongly impli-
cate the integrin defined by mAb H9.2 as the signal-trans-
ducing molecule involved in the induction of 1164 produc-
tion by ECM proteins, they fail to explain why this response
is so readily inhibited by anti-CD3 or the anti-clonotypic mAb.
To more accurately define the role of the TCR in this process
of activation, TCR loss mutants were generated from the
T195/BW hybrid by chemical mutagenesis followed by nega-
tive selection with the anti-clonotypic mAb P10/56 and com-
plement. Five cloned lines were selected on the basis of their
lack of reactivity with the anti-clonotypic mAb by FACS anal-
ysis and all expressed levels of the integrin comparable to the
parental cell line (data not shown). The clones appeared to
retain the phenotypic characteristics of the parental line as
they continued to grow adherent and to spread on plastic.
Northern blot analysis revealed that all five mutant lines had
lost expression of the TCR y chain (data not shown). None
of the mutants produced I1J4 constitutively (Table 7) or after
stimulation with immobilized F10/56, but all were capable
of IIJ4 production after stimulation with the combination
of PMA and ionomycin. These results demonstrate an abso-
lute requirement for coexpression ofthe TCR for activation
of T195/BW by ECM proteins.
Discussion
The studies described in the present report are an exten-
sion of our previous reports on the characteristics of y/S T
cell lines derived from murine skin (25-27) and have specifically
addressed the mechanisms responsible for the production of
cytokines by several DETC linesin the absence of exogenous
stimulation. 3 of 12 DETC lines generated from C3H mouse
skin constitutively produced lymphokine. On closer investi-
gation, two of the lines (Y93A and Y245) were shown to
produce GM-CSF and one (T195) 114. After adaptation of
the T195/BW hybridoma to serum-free culture conditions,
cessation of the "spontaneous" production of IIr4 was ob-
served and IIT4 productioncould then be induced by the ad-
Table 7.
￿
Production of IL-4 by Parental and TCR Loss Mutants
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Five mutants failing to express the TCRepitope recognized by F10/56
were prepared as described. TheTCRloss mutants andparental line were
incubated overnight in RPMl containing 10% FCS, plates coated with
F10/56 (20 Rg/ml), or PMA/lonomycinfor18 h. Culture supernatants
were then analyzed for IL-4 content as described in Table 2.
Units per milliliter of IL-4.
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dition of RGD-containing ECM proteins to the culture. The
response to the ECM proteins could be completely inhibited
by a mAb to the murine VNR. However, the induction of
IIr4 production could also be inhibited by anti-CD3 and by
an anti-clonotypic mAb to the TCRy/b of T195. As TCR
y/b loss mutants of T195/BW also failed to respond to ECM
proteins, these data demonstrate that engagement ofthe VNR
by its ligand is necessary, but not sufficient, for the induc-
tion of IIs4 production and that the TCR-y/S also plays a
role in the response to ECM proteins.
One possible explanation for our findings was that the TCR
y/S expressed by T195 recognized a non-RGD site on the
ECM proteins as its ligand, and that engagement of this site
by the TCR together with engagement of the RGD site by
the VNR were both required for the induction ofHA produc-
tion. The active components in serum were found to be the
ECM proteins, vitronectin, fibronectin, and fibrinogen (data
not shown). Since the RGDS peptide was efficient at inhibiting
lymphokine productionby the hybridoma grown in the pres-
ence of serum, it would appear that proteins containing the
RGDS sequence are the only components of serum that were
responsible for triggering T195/BW. It is rather unlikely that
the ECM proteins were serving as antigen for the TCRy/6
since fibronectin and vitronectin share minimal sequence ho-
mologies other than RGDS. Moreover, fibronectin only stimu-
lated when firmly immobilized on plastic and no evidence
couldbe obtained that soluble fibronectin couldbe processed
and presented by the hybridoma cells (data not shown) . The
ability of the synthetic 20 amino acid RGDS-containing pep-
tide, PepTite 2000, to efficiently activate IIJ4 production is
consistent with the view that RGDS is both necessary and
sufficient for both adhesion and cell activation. Although it
is formally possible that the VNR and the TCR could both
recognize the RGDS sequence, we regard this possibility as
unlikely.
The ability ofmAb H9.2 to completelyinhibit the produc-
tion of1174 by T195/BW strongly suggests that the integrin
identified by this mAb is involved in the process of T cell
activation. We believe that this integrin is the VNR because
it is reactive with an antiserum to the human VNR and is
not reactive with antisera specific for the human integrin /31
or /32 COOH-terminal amino acid sequences; furthermore,
in detergent extracts of T195/BW, all of the molecules reac-
tive with mAb H9.2 are also reactive with an antiserum to
the human /33 COOH-terminal sequence (24a).
Adhesion of the cells to the culture dish was insufficient
to induce T cell activation as adhesion mediated by an im-
mobilized mAb to the common leukocyte antigen (CD45)
failed to induce IIr4 production. Thus, it is likely that the
interaction and engagement of the VNR with immobilized,
but not soluble, ECM proteins, lead to signal transduction
mediated by the integrin. Integrins have been implicated as
playing a role in adhesion, motility, hemostasis, development,
induction of differentiation, and cytoskeletal reorganization
(21, 37). It is likely that integrins function as signal trans-
ducers because they interact with molecules of both the ex-
tracellular matrix and with the cytoskeleton and bind the
of T1951BW
TCR loss mutant
Culture conditions 5.13 1.1 5.5 5.4 3C Parental
FCS 0.1' 0.0 0.0 0.0 0.0 1,333
Anti-clonotype (F10/56) 0.0 0.0 0.0 0.0 0.0 435
PMA+lonomycin 7,143 1,852 571 1,176 833 200cytoskeletal protein talin (38). Although the biochemical basis
for this interaction has not yet been determined, the failure
of mutant integrinal chains that lack a cytoplasmic domain
to localize efficiently in focal contacts even though the mu-
tant integrins are exported to the cell surface and bind fibro-
nectin (39) strongly implicates the cytoplasmic portion of
the a chain in this process.
Although some evidence exists for the role of integrins
in the enhancement of phagocytosis of opsonized particles
by monocytes (40), the induction of the respiratory burst in
human neutrophils (41), and the regulation of stromelysin
gene expression in fibroblasts (42), the ability of the inte-
grins to function as signal transducers in the process of T
cell activation and lymphokine production has not been ex-
haustively analyzed. Wacholtz et al. (43) have demonstrated
that co-stimulation of resting CD4+ T cells with immobi-
lized anti-CD3 can be enhanced by co-stimulation with an
anti-LFA-1 mAb and that crosslinking of LFA1 and CD3
simultaneously produced a prolongation in the increase in
[Ca2 +j; and enhancement of both IL2 production and pro-
liferation. Similarly, Matsuyama et al. (44) have shown that
fibronectin synergizes with suboptimalconcentrations of anti-
CD3 to induce a proliferative response of resting CD4+ T
cells and that the stimulatory effects of fibronectin could be
inhibited by RGDS and a mAb to VLA-5. In contrast to our
findings, fragments of fibronectin containing the cell adhe-
sion site alone were not as effective as the intact molecule
in inducing T cell activation.
Although the ability of ECM proteins to activate T195/BW
was mediated by the VNR, expression and engagement of
the VNR were not sufficientto induce IL-4 production. The
inhibitory effects of soluble anti-CD3 and the anti-clonotypic
mAb to the T195 TCR raised the possibility that the TCR/
CD3 complex also played an active role in the regulation of
cytokine production by the DETC lines. Furthermore, the
coexpression of the TCR on the surface of the T195/BW
cells was required for activation as mutants that lacked the
Cy4, VS6 TCR failed to respond to stimulation by serum,
ECM proteins, or PepTite 2000.
There are a number ofpossible explanations for the require-
ment of TCR expression for integrin-mediated activation.
First, it is unlikely that the VNR and the TCR complex are
physically associated sincetheVNRdoes not comodulate with
the TCR (data not shown). A second possibility is that acti-
vation via the VNR is analogous to activation via other T
cell surface antigens that mediate so-called alternative pathways
of activation. Thus, mAbs to Thy-1 (45, 46), Ly-6 (47), and
CD2 (48, 49) are all capable of stimulating lymphokine
production by murine or human T cells and their abilities
to induce lymphokine production are absolutely dependent
on coexpression of the TCR, but engagement of the TCR
by its ligand is not required. However, it is important to note
that the VNRidentified by mAb H9.2 is expressed by many
other T cell clones (both y/S and ci//3), none ofwhich pro-
duce lymphokines constitutively (20; and Roberts, K., and
E. M. Shevach, Manuscript in preparation) .
An alternative model that is most compatible with our
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data is that not only is coexpression of the VNR and TCR
required for the induction of 11,4 production, but that the
TCR must also be engaged by its ligand, most likely a cell
surface antigen expressed by the hybridoma itself. A specific
correlation between the spontaneous productionof IL2 and
expression of a TCR-y/b usingCy4 and frequently VS6 has
been described (15, 50) in a large panel of T cell hybrids de-
rived from newborn thymus. In the present report, the three
cell lines that produced lymphokines "constitutively" in cul-
ture also expressed a TCR utilizing the Cy4 and V66 gene
products. Taken together, these observations strongly favor
theview that the combination ofCy4 with a restrictednumber
of b chains (particularly VS6) results in expression of a TCR
that is likely to recognize an autoantigen. However, the failure
of the cell to be triggered in serum-free medium even under
high density culture conditions suggests that the TCR ex-
pressed by T195/BW is oflow affinity and requires theVNR
to function as an "accessory molecule" to produce a high
affinity interaction in a manner similar to that proposed for
CD4/CD8 and MHC class II/class I, CD2 and LFA3, as
well as LFA-1 and ICAM-1 (51). However, in the case of
T195/BW the ligand for theVNR accessory molecule need
not be present on the APC.
It is very difficult to address the question ofthe expression
of the VNR on Cy4, VS6 expressing T cells in vivo. No
mAbs are yet available that would facilitate the isolation of
this T cell subset and we were unable to identify the VNR
on unfractionated thymocytes, lymph node cells, spleen cells
(20), DETC in situ, and on populations of adult thymocytes
enriched for "double-negative" T cells that contained a high
percentage of y/S cells. On the other hand, since the VNR
is inducible on many ca/O T cells by chronic activation in
vitro, the manner in which its expression is regulated in vivo
may be complex and it is difficult to exclude the possibility
that a very small number of activated cells express this mole-
cule both in the thymus and in peripheral lymphoid tissues.
In addition, ECM patients are actively synthesized by inflam-
matory cells and T cells expressing the VLA-1 and VLA-2
antigens can be found in sites ofinflammation (52); it is there-
fore possible that the VNR and other members of the inte-
grin family may function as accessory molecules by recog-
nizing ECM proteins on the surface of APCs and assist the
TCRin the recognition ofprocessed antigens on the surface
of the same cell. Further studies of the mechanisms by which
the VNR is induced and the possible role of cytokines in
the induction process should shed light on the role that it
plays in the function of both a/,(3 and y/S T cells.
Lastly, the nature of the autoantigen recognizedby T cells
that express the Cy4V66 TCR has not been defined. O'Brien
et al. (15) demonstrated that many of the hybridomas gener-
ated from newborn thymus that spontaneously produced IL-2
were also reactive with PPD from Mycobacterium tuberculosis
and with a member of the heat shock family of proteins. Al-
though these observations were interpreted as indicating that
the physiologic ligand of the TCR-y/S is likely to be an au-
tologous heat shockprotein, probably a member ofthe GroEL
family (17), it is also possible that certain subpopulations ofy/6 T cells might recognize bacterial antigens as their physi-
ologic ligand and use the VNR or another member of the
integrin family as accessory molecules. Their reactivitywith
autologousheat shock proteins would then be considered to
be a crossreaction. It is of particular interest that a number
ofbacteria have been shown to interact with ECM proteins.
Both fibronectin and fibrinogen bind to Staphylococcus aureus
(53-55) as well as Calmette-Guerin bacillus (BCG) (56) and
vitronectin binds to streptococci (57). It has also recently been
shown that the integrin 01 chains are receptors for invasin,
a protein involved in the penetration of bacteria into non-
phagocytic cells (58). The combined use of certain -y/6
receptors together with the integrins may prove to be an im-
portant mechanism for the generation of host resistance to
bacterial antigens. The VNR may play a particularly impor-
tant role in this process as it is a promiscuous integrin that
is capable ofinteracting with bacteria coated with one of several
ECM patients or even bacterial antigens that contain an RGD
sequence.
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